Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessCompaniesTimeline of Dr Reddy's regulatory issues and stock price movement

    Timeline of Dr Reddy's regulatory issues and stock price movement

    The latest jab is a part of the never-ending saga of regulatory compliance woes the company has been facing starting November 2015

    Viswanath Pilla
    September 08, 2017 / 15:33 IST
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Dr Reddy’s said on Friday that it has received six major observations from German drug regulator for its Duvvada formulation facility. The company also said renewal of its EU-GMP certification next year will be based on the regulator’s satisfaction of the company’s corrective and preventive action taken at the plant.

      The latest jab is a part of the never-ending saga of regulatory compliance woes the company has been facing starting November 2015 when USFDA sent a warning letter. The company has lost almost half of its market value since then. The warning letter slowed down new approvals significantly, hitting the company sales.

      Here is a timeline of Dr. Reddy’s regulatory problems and the movement in its stock price

      Exhibits08092017119

      Exhibits080920171192

      Related stories

      Data infographic by Ritesh Presswala

      Viswanath Pilla
      Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
      first published: Sep 8, 2017 02:01 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347